Sterira

Every dose, perfectly sterile.

Seed · Jan 2025 Sterile fill-finish AI Active

The autonomous operations layer for sterile pharmaceutical fill-finish — sterile assurance, accurate fills, zero human-borne contamination, and fewer rejects and deviations.

Illustrative profile. Sterira is presented to show how AWSM VC lists a portfolio company. Concept and funding date are indicative; founders, team size, and roles are illustrative until publicly announced.

Active founders

Elena Roth

Co-founder & CEO

Aseptic-processing lead who spent her career eliminating human intervention from the fill line.

LinkedIn →

David Okafor

Co-founder & CTO

Vision and robotics engineer behind Sterira's contamination-control autonomy.

LinkedIn →

Latest news

Pharmaceutical Technology · 2025 Sterira raises seed for autonomous fill-finish Illustrative
BioProcess International · 2025 Removing the human from the sterile core Illustrative

Jobs at Sterira

View all jobs →

Founding Robotics Engineer

Basel / Hybrid · 5+ years

Apply →

Aseptic Solutions Lead

Remote (EU) · €95K – €130K

Apply →

Applied AI Engineer

Basel · 3+ years

Apply →

Own a constraint like this?

If you're building the layer Physical AI can't scale without, we want to hear about it.

Tell us your constraint →